4
Changes in Ownership
RESMED INC Filed Acc 0001127602-21-026987
Chief Financial Officer sold 5,000 shares at $253.37 ($1,266,850)
- Chief Financial Officer acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sandercock Brett · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-11 | Exercise or conversion : show line 1 in the form | +2,500 | $57.76 | $144,400 | 89,786 | D |
| 2021-10-11 | Sale : show line 2 in the form | −5,000 | $253.37 | $1,266,850 | 84,786 | D |
| Open-market sales · 5,000 sh · avg $253.37 · $1,266,850 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-11 | Exercise or conversion : show line 3 in the form ResMed Common Stock Options | −2,500 | 25,000 | D |
Loading xslF345X03/form4.xml…